-
Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor and Interleukin 34 in Patients with Chronic Hepatitis C as Serological Fibrosis Markers
Mona M. Abdulwehab, Aziza A. Ahmed, Wafaa M. Elzefzafy, Reham Sabry, Abeer Mohammed Abdul-Mohymen
Open Journal of Immunology
Vol.11 No.2,
June
30,
2021
DOI:
10.4236/oji.2021.112002
-
Role of Urokinase-Type Plasminogen Activator Receptors as an Early Detector for Treatment Outcome in Adult Acute Myeloid Leukemia in Egyptian Patients
Hanan R. Nassar, Eman Z. Kandeel, Laila A. E. Hegazy, Amany M. Helal, Tarek Darwish, Soad A. Eltokhy
Journal of Cancer Therapy
Vol.6 No.11,
October
14,
2015
DOI:
10.4236/jct.2015.611104
-
Soluble urokinase-plasminogen activator receptor (suPAR) and natural phosphorylcholine IgM antibodies in patients at clinical onset of diabetes mellitus
Magnus Hillman, Mona Landin-Olsson
Journal of Diabetes Mellitus
Vol.1 No.4,
November
8,
2011
DOI:
10.4236/jdm.2011.14013
-
Association of the plasminogen activator inhibitor-1(PAI-1) gene 4G/5G promoter polymorphism in Buerger's disease (Tromboangiitis obliterans)
Sinasi Manduz, Nurkay Katrancioglu, Oguz Karahan, Oztürk Ozdemir
Health
Vol.2 No.5,
May
27,
2010
DOI:
10.4236/health.2010.25068
-
Description of Prescribing Practices of Intrapleural Tissue Plasminogen Activator and Intrapleural DNase Administration at a Tertiary Academic Medical Center
Heather Torbic, Gaspar Hacobian, Nahal Beik
Pharmacology & Pharmacy
Vol.5 No.9,
August
19,
2014
DOI:
10.4236/pp.2014.59099
-
A Review on Recombinant Tissue Plasminogen Activator: In Vitro Synthesis and Its Use in Treatment of Acute Ischemic Stroke
Prabhu Sukumaran, Eldho K. Poulse
Open Access Library Journal
Vol.1 No.3,
June
17,
2014
DOI:
10.4236/oalib.1100603
-
A Randomized Prospective Assessment of Safety and Effectiveness of Instillation of Tissue Plasminogen Activator in the Management of Intra-Abdominal Abscesses
Suhas A. Kotecha, Murray R. Asch, Andrew J. Myers, Dheeraj K. Rajan
Open Journal of Radiology
Vol.6 No.3,
August
5,
2016
DOI:
10.4236/ojrad.2016.63027
-
Genetic and Metabolic Determinants of Plasminogen Activator Inhibitor 1 (PAI-1) in Tunisian Type 2 Diabetes Patients
Mohamed Moustapha, Molka Chadhli-Chaieb, Touhami Mahjoub, Larbi Chaieb
Open Journal of Endocrine and Metabolic Diseases
Vol.7 No.6,
June
30,
2017
DOI:
10.4236/ojemd.2017.76013
-
Effects of Fermented Rice Vinegar Kurozu and Its Sediment on Inflammation-Induced Plasminogen Activator Inhibitor 1 (PAI-1) Increase
Naoki Ohkura, Fumiko Kihara-Negishi, Akira Fujii, Hiroaki Kanouchi, Katsutaka Oishi, Gen-Ichi Atsumi, Masanobu Nagano
Food and Nutrition Sciences
Vol.9 No.3,
March
29,
2018
DOI:
10.4236/fns.2018.93018
-
Localized Administration of Tissue Plasminogen Activator through the Ophthalmic Artery in the Setting of Central Retinal Artery Occlusion
Deanna Ingrassia Miano, Gilbert Xue, Erika White, Faisal Ridha Al-Timimi
Case Reports in Clinical Medicine
Vol.11 No.5,
May
17,
2022
DOI:
10.4236/crcm.2022.115023
-
The Frequency of rs1799889 in Plasminogen Activator Inhibitor Type-1 Gene in Sudanese Type 2 Diabetic Patients, Gezira State, Sudan, 2020-2021
Rowida Eljack Ibrahim, Sanaa Elfatih Hussein Ibrahim, Khalid Abdelsamea Mohamedahmed, Abdarahim Ali Babikir Haj Alzebar, Rania Ali Abdella Mohamed, Adil Mergani Babiker, Bakri Yousif Mohamed Nour
Open Journal of Applied Sciences
Vol.12 No.2,
February
16,
2022
DOI:
10.4236/ojapps.2022.122012
-
The Interaction of Heat and Lipopolysaccharide on the Expression Levels of Receptor Activator of NF-κB Ligand and Osteoprotegerin in Human Periodontal Ligament Cells
Lan Zhang, Qinghua Zheng, Xuedong Zhou, Lu Tang, Qian Wang, Xiaoyu Li, Dingming Huang
Open Journal of Stomatology
Vol.5 No.10,
October
29,
2015
DOI:
10.4236/ojst.2015.510030
-
Oxidized phospholipids modify plasminogen and apolipoprotein(a): Implications for vascular disease
Angelo M. Scanu, Diana M. Stafforini, Celina Edelstein
American Journal of Molecular Biology
Vol.2 No.2,
April
28,
2012
DOI:
10.4236/ajmb.2012.22012
-
SRT1720, a SIRT1 Activator, Aggravates Bleomycin-Induced Lung Injury in Mice
Shingo Imanishi, Ryuji Hayashi, Tomomi Ichikawa, Kensuke Suzuki, Masakiyo Sasahara, Takashi Kondo, Hirofumi Ogawa, Kazuyuki Tobe
Food and Nutrition Sciences
Vol.3 No.2,
February
27,
2012
DOI:
10.4236/fns.2012.32024
-
Docking of Glycokinase with Oxo, Sulfo, and Seleno Derivatives of the Carboxamide Activator S41
Glodi M. Ndefi, Albert S. Lundemba, Dikima D. Bibelayi, Jason T. Kilembe, Eliakim M. Kambale, Céline W. Kadima, Zéphyrin G. Yav
Crystal Structure Theory and Applications
Vol.9 No.2,
May
9,
2020
DOI:
10.4236/csta.2020.92003
-
Study on the Influence of Alkali Activator Solutions on Strength Improvement of Pozzolan Calcium Hydroxide Binders
Asson Sifueli Malisa, Duwa Hamisi Chengula
Journal of Geoscience and Environment Protection
Vol.10 No.12,
December
30,
2022
DOI:
10.4236/gep.2022.1012018
-
Antiepileptic Drug-Induced Apoptosis Was Prevented by L-Type Calcium Channel Activator in Cultured Rat Cortical Cells
Tsuneo Takadera, Masashi Aoki, Naruto Nakanishi
Open Journal of Apoptosis
Vol.6 No.2,
April
10,
2017
DOI:
10.4236/ojapo.2017.62002
-
Properties of Geopolymers Made from Fired Clay Bricks Wastes and Rice Husk Ash (RHA)-Sodium Hydroxide (NaOH) Activator
Lynn Myllyam Beleuk à Moungam, Hawa Mohamed, Elie Kamseu, Ndigui Billong, Uphie Chinje Melo
Materials Sciences and Applications
Vol.8 No.7,
July
5,
2017
DOI:
10.4236/msa.2017.87037
-
Tyrosine kinase receptor B isoforms alter APP and BACE1 endogenous levels independently of BDNF
Sara Ansaloni, Brian P. Leung, Aditi Dubey, Aleister J. Saunders
Advances in Alzheimer's Disease
Vol.1 No.3,
December
31,
2012
DOI:
10.4236/aad.2012.13012
-
−675 4G/5G and −844 G/A of Plasminogne Activator Inhibitor-1 (Pai-1) Gene Polymorphisms and Type 2 Diabetes Mellitus in Tunisia: Case-Control Study
Mohamed Moustapha, Molka Chadhli-Chaieb, Touhami Mahjoub, Larbi Chaieb
Open Journal of Endocrine and Metabolic Diseases
Vol.9 No.7,
July
30,
2019
DOI:
10.4236/ojemd.2019.97008